Steven Mazlin
Neurology · Langhorne, PANPI 1508845504
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,968 and has fallen 98.8% since, to $23 in 2025.
Across 147 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$345
- Boston Scientific$304
- Acorda Therapeutics, Inc$197
- Novartis$166
- Biogen$133
- Avanir Pharmaceuticals, Inc.$115
- plus $1K from 28 others
What the payments were for
- Speaking & faculty fees$1224%
- Food & beverage$2,59796%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $345 |
| Boston Scientific | 3 | $304 |
| Acorda Therapeutics, Inc | 7 | $197 |
| Novartis | 12 | $166 |
| Biogen | 11 | $133 |
| Avanir Pharmaceuticals, Inc. | 7 | $115 |
| UCB, Inc. | 5 | $103 |
| EMD Serono, Inc. | 6 | $102 |
| AstraZeneca | 5 | $101 |
| Amneal Pharmaceuticals LLC | 6 | $100 |
| Eisai Inc. | 5 | $88 |
| Lilly USA, LLC | 6 | $87 |
| Teva Pharmaceuticals USA, Inc. | 5 | $85 |
| Sanofi | 4 | $83 |
| Amgen | 4 | $79 |
| Zyla Life Sciences, Inc. | 4 | $64 |
| Mallinckrodt Enterprises LLC | 3 | $61 |
| Sunovion Pharmaceuticals Inc. | 3 | $56 |
| Upsher-smith Laboratories LLC | 3 | $52 |
| Promius Pharma LLC | 3 | $43 |
| Acadia Pharmaceuticals Inc | 3 | $39 |
| Genentech USA, Inc. | 2 | $37 |
| Johnson & Johnson | 1 | $35 |
| Tersera Therapeutics LLC | 2 | $32 |
| Merz North America, Inc. | 1 | $30 |
| MDD US Operations, LLC | 2 | $28 |
| Bayer | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Aquestive Therapeutics, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 2 | $22 |
| Lundbeck LLC | 1 | $19 |
| Iroko Pharmaceuticals, LLC | 1 | $16 |
| Adamas Pharmaceuticals, Inc. | 1 | $12 |
| Bristol Myers Squibb | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,719 in reported general payments places this provider in the 65th percentile of 941 neurology providers in Pennsylvania.
Other neurology in Langhorne
- Daniel KremensPhiladelphia$1.8M
- Thomas LeistPhiladelphia$1.4M
- Jill Giordano FarmerPhiladelphia$1.2M
- Ravi DukkipatiYork$936K
- Brad KleinAbington$927K
- Stephanie Nahas-GeigerPhiladelphia$786K
- John KhouryAbington$686K
- Amit Bar-OrPhiladelphia$596K
- Behrang SaminejadAllentown$594K
- Anoopum GuptaPittsburgh$592K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.